Form 4: DarioHealth Director Hila Karah Reports Acquisition of 70,000 Shares

Director Hila Karah reports acquiring 70,000 shares of DarioHealth Corp. on March 6, 2024.

Summary

• On March 6, 2024, Hila Karah, a director of DarioHealth Corp., acquired 70,000 shares of common stock.
• The shares were acquired at a price of $0.
• Following the transaction, Karah directly owns 219,290 shares of DarioHealth Corp.
• 50% of the acquired shares vested immediately on the grant date, and the remaining 50% will vest in quarterly installments over a two-year period starting March 31, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of a director's stock acquisition. The vesting schedule is typical.

Positives

• A director increasing their stake in the company can be seen as a positive signal.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding 10% or more of a company's shares) buy or sell stock in their own companies. These filings provide transparency to the market and allow investors to track insider activity, which can sometimes offer insights into a company's prospects.

Key Dates